Certain factors can significantly increase patients’ risk of developing oral cancer. These include tobacco use, age, gender, alcohol use, and human papillomavirus (HPV). As such, it’s important for clinicians to risk-profile their patients, in order to help them manage their lifestyle choices during as health check-up.
The BeVigilant™ OraFusion™ system from Vigilant Biosciences® enables clinicians to conduct a quick, accurate pre-diagnostic test in every appointment. The device analyses a patient’s saliva for the biomarkers associated with oral cancer, to establish their risk level. Ideal for chairside use, the BeVigilant™ OraFusion™ system produces a result in 15 minutes or less, to give you and your patients peace of mind.
Find out more about the BeVigilant™ OraFusion™ system today – contact the team.
For more information, please visit www.vigilantbiosciences.com or email info@vigilantbiosciences.com
